DarioHealth Corp. Statistics
Share Statistics
DarioHealth Corp. has 34.10M shares outstanding. The number of shares has increased by 10.34% in one year.
| Shares Outstanding | 34.10M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.35% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 28.05M |
| Failed to Deliver (FTD) Shares | 3.91K |
| FTD / Avg. Volume | 4.1% |
Short Selling Information
The latest short interest is 1.84M, so 5.38% of the outstanding shares have been sold short.
| Short Interest | 1.84M |
| Short % of Shares Out | 5.38% |
| Short % of Float | 6.67% |
| Short Ratio (days to cover) | 25.02 |
Valuation Ratios
The PE ratio is -0.82 and the forward PE ratio is -1.08.
| PE Ratio | -0.82 |
| Forward PE | -1.08 |
| PS Ratio | 2.4 |
| Forward PS | 0.7 |
| PB Ratio | 0.84 |
| P/FCF Ratio | -1.58 |
| PEG Ratio | n/a |
Enterprise Valuation
DarioHealth Corp. has an Enterprise Value (EV) of 41.25M.
| EV / Earnings | -0.69 |
| EV / Sales | 2.03 |
| EV / EBITDA | -0.76 |
| EV / EBIT | -0.73 |
| EV / FCF | -1.33 |
Financial Position
The company has a current ratio of 3.79, with a Debt / Equity ratio of 0.49.
| Current Ratio | 3.79 |
| Quick Ratio | 3.38 |
| Debt / Equity | 0.49 |
| Total Debt / Capitalization | 33.01 |
| Cash Flow / Debt | -1.06 |
| Interest Coverage | -87.11 |
Financial Efficiency
Return on equity (ROE) is -1.02% and return on capital (ROIC) is -64.15%.
| Return on Equity (ROE) | -1.02% |
| Return on Assets (ROA) | -0.62% |
| Return on Capital (ROIC) | -64.15% |
| Revenue Per Employee | 73.74K |
| Profits Per Employee | -215.32K |
| Employee Count | 276 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 2.84 |
Taxes
| Income Tax | 64.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -57.63% in the last 52 weeks. The beta is 1.51, so DarioHealth Corp.'s price volatility has been higher than the market average.
| Beta | 1.51 |
| 52-Week Price Change | -57.63% |
| 50-Day Moving Average | 0.89 |
| 200-Day Moving Average | 1.17 |
| Relative Strength Index (RSI) | 44.82 |
| Average Volume (20 Days) | 95.46K |
Income Statement
In the last 12 months, DarioHealth Corp. had revenue of $20.35M and earned -$59.43M in profits. Earnings per share was $-1.93.
| Revenue | 20.35M |
| Gross Profit | 5.98M |
| Operating Income | -56.19M |
| Net Income | -59.43M |
| EBITDA | -54.38M |
| EBIT | -56.19M |
| Earnings Per Share (EPS) | -1.93 |
Balance Sheet
The company has $36.80M in cash and $29.54M in debt, giving a net cash position of $7.26M.
| Cash & Cash Equivalents | 36.80M |
| Total Debt | 29.54M |
| Net Cash | 7.26M |
| Retained Earnings | -349.36M |
| Total Assets | 109.95M |
| Working Capital | 10.68M |
Cash Flow
In the last 12 months, operating cash flow was -$30.38M and capital expenditures -$584.00K, giving a free cash flow of -$30.96M.
| Operating Cash Flow | -30.38M |
| Capital Expenditures | -584.00K |
| Free Cash Flow | -30.96M |
| FCF Per Share | -1.09 |
Margins
Gross margin is 29.4%, with operating and profit margins of -276.09% and -292%.
| Gross Margin | 29.4% |
| Operating Margin | -276.09% |
| Pretax Margin | -291.68% |
| Profit Margin | -292% |
| EBITDA Margin | -267.19% |
| EBIT Margin | -276.09% |
| FCF Margin | -152.14% |
Dividends & Yields
DRIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -257.33% |
| FCF Yield | -121.08% |
Analyst Forecast
The average price target for DRIO is $4, which is 433.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $4 |
| Price Target Difference | 433.3% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Nov 18, 2019. It was a backward split with a ratio of 1:20.
| Last Split Date | Nov 18, 2019 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -5.99 |
| Piotroski F-Score | 2 |